See the DrugPatentWatch profile for stelara
Can Stelara (ustekinumab) be used to treat ulcerative colitis?
Yes. Stelara (ustekinumab) is used to treat ulcerative colitis in people who need medication to control inflammation in the colon [1].
Is Stelara approved for ulcerative colitis, or only for Crohn’s?
Stelara is used for ulcerative colitis as well as Crohn’s disease [1]. Approval and use are based on clinical trial evidence for inflammatory bowel disease, not just Crohn’s [1].
When would doctors choose Stelara for ulcerative colitis?
Doctors typically consider biologic therapy like Stelara for ulcerative colitis when symptoms are moderate to severe and require systemic treatment to reduce inflammation [1].
How does Stelara work in ulcerative colitis?
Stelara is an immunosuppressive biologic (it targets inflammatory pathways involved in immune signaling) [1]. That mechanism is part of why it can help reduce the inflammation that drives ulcerative colitis symptoms [1].
What patients often ask: is Stelara a quick fix or long-term therapy?
For ulcerative colitis, treatment is generally used as a longer-term control strategy rather than a short course, with dosing given over time to maintain control of inflammation [1].
Safety and monitoring considerations
Like other immunosuppressive biologics, Stelara can affect the immune system, so patients usually need medical follow-up for infection risk and other adverse effects [1].
Sources:
[1] https://www.stelarahcp.com/indications/ulcerative-colitis.html